Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38:101019

Article  PubMed  PubMed Central  Google Scholar 

Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36(3):168–174

Article  CAS  PubMed  Google Scholar 

Martelletti P, Bentivegna E, Spuntarelli V, Luciani M (2021) Long-COVID headache. SN Compr Clin Med 3(8):1704–1706

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tana C, Bentivegna E, Cho SJ, Harriott AM, García-Azorín D, Labastida-Ramirez A et al (2022) Long COVID headache. J Headache Pain 23(1):93

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gómez-Dabó L, Melgarejo-Martínez L, Caronna E, Pozo-Rosich P (2023) Headache in COVID-19 and Long COVID: to know facts for clinical practice. Curr Neurol Neurosci Rep 23(10):551–560

Article  PubMed  Google Scholar 

Hussein M, Fathy W, Eid RA, Abdel-Hamid HM, Yehia A, Sheemy MS et al (2021) Relative frequency and risk factors of COVID-19 related headache in a sample of Egyptian Population: A Hospital-based study. Pain Med 22(9):2092–2099

Article  PubMed  Google Scholar 

Fernández-de-Las-Peñas C, Gómez-Mayordomo V, García-Azorín D, Palacios-Ceña D, Florencio LL, Guerrero AL et al (2021) Previous history of migraine is Associated with fatigue, but not Headache, as long-term Post-COVID Symptom after severe Acute Respiratory SARS-CoV-2 infection: a case-control study. Front Hum Neurosci 15:678472

Article  PubMed  PubMed Central  Google Scholar 

Fernández-de-Las-Peñas C, Navarro-Santana M, Gómez-Mayordomo V, Cuadrado ML, García-Azorín D, Arendt-Nielsen L et al (2021) Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol 28(11):3820–3825

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A et al (2022) Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalalgia 42(8):804–809

Article  PubMed  Google Scholar 

Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144

Article  CAS  PubMed  PubMed Central  Google Scholar 

Magdy R, Elmazny A, Soliman SH, Elsebaie EH, Ali SH, Abdel Fattah AM et al (2022) Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case-control study. J Headache Pain 23(1):101

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133–146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radke J, Meinhardt J, Aschman T, Chua RL, Farztdinov V, Lukassen S et al (2024) Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19. Nat Neurosci 27(3):409–420

Article  CAS  PubMed  Google Scholar 

Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L et al (2024) Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27(3):421–432

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rozen T, Swidan SZ (2007) Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47(7):1050–1055

Article  PubMed  Google Scholar 

Rozen TD (2014) New daily persistent headache: an update. Curr Pain Headache Rep 18(7):431

Article  PubMed  Google Scholar 

Steinmetz A, Bahlmann S, Bergelt C, Broker BM, Ewert R, Felix SB et al (2023) The Greifswald Post COVID Rehabilitation Study and Research (PoCoRe)-Study design, characteristics and evaluation tools. J Clin Med. ;12(2)

Olesen J (2018) International classification of Headache disorders. Lancet Neurol 17(5):396–397

Article  PubMed  Google Scholar 

Winter T, Friedrich N, Lamp S, Schäfer C, Schattschneider M, Bollmann S et al (2020) The Integrated Research Biobank of the University Medicine Greifswald. Open J Bioresources

Bolay H, Gül A, Baykan B (2020) COVID-19 is a real headache! Headache 60(7):1415–1421

Article  PubMed  PubMed Central  Google Scholar 

Silvestro M, Tessitore A, Orologio I, Sozio P, Napolitano G, Siciliano M et al (2021) Headache worsening after COVID-19 vaccination: an online questionnaire-based study on 841 patients with migraine. J Clin Med. ;10(24)

Ashina M, Migraine (2020) N Engl J Med 383(19):1866–1876

Article  CAS  PubMed  Google Scholar 

Martins LB, Duarte H, Ferreira AVM, Rocha NP, Teixeira AL, Domingues RB (2015) Migraine is associated with altered levels of neurotrophins. Neurosci Lett 587:6–10

Article  CAS  PubMed  Google Scholar 

Süße M, Kloetzer C, Strauß S, Ruhnau J, Overeem LH, Bendig M et al (2024) Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study. J Headache Pain 25(1):46

Article  PubMed  PubMed Central  Google Scholar 

Bø SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ et al (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29(3):365–372

Article  PubMed  Google Scholar 

Güzel I, Taşdemir N, Çelik Y (2013) Evaluation of serum transforming growth factor β1 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357–362

Article  PubMed  Google Scholar 

Bolay H, Karadas Ö, Oztürk B, Sonkaya R, Tasdelen B, Bulut TDS et al (2021) HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain 22(1):94

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarchielli P, Alberti A, Floridi A, Gallai V (2001) Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 57(1):132–134

Article  CAS  PubMed  Google Scholar 

Steinmetz A, Gross S, Lehnert K, Lücker P, Friedrich N, Nauck M et al (2023) Longitudinal clinical features of Post-COVID-19 Patients-Symptoms, fatigue and physical function at 3- and 6-Month Follow-Up. J Clin Med. ;12(12)

Carrión-Nessi FS, Ascanio LC, Pineda-Arapé AG, Omaña-Ávila ÓD, Mendoza-Millán DL, Romero SR et al (2023) New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study. BMC Infect Dis 23(1):877

Article  PubMed  PubMed Central  Google Scholar 

Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpotter K et al (2024) Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. EClinicalMedicine 69:102456

Article  PubMed  PubMed Central  Google Scholar 

Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpötter K et al (2024) Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine 69:102456

Article  PubMed  PubMed Central  Google Scholar 

Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R (2006) Frequency of headache is related to sensitization: a population study. Pain 123(1–2):19–27

Article  CAS  PubMed  Google Scholar